ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08905
-0,04%
Bitcoin
67.035,73
0,14%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Marker Therapeutics (delisted) (TPIV)

  7. Marker Therapeutics (delisted) (TPIV) News

TPIV

TapImmune, Inc. (TPIV)

Marker Therapeutics (delisted)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TPIV
DatumZeitQuelleÜberschriftSymbolFirma
19/10/201823h10Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201822h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201822h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201822h34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201822h33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201822h31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201822h54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201822h54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201822h54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201822h54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201822h53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201822h52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201822h52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201822h51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201822h51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201822h51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201822h50Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201822h50Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201822h49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201822h02Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201822h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201817h45PR Newswire (US)TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And FinancingNASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201814h56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201814h54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201814h52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201814h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201814h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
10/10/201822h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
10/10/201812h30PR Newswire (US)TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded b...NASDAQ:TPIVMarker Therapeutics (delisted)
25/09/201823h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
 Showing the most relevant articles for your search:NASDAQ:TPIV

Kürzlich von Ihnen besucht

LSE
IAEA
NASDAQ
TBLD
Thomburg Income Builder ...
USOTC
ADOIF
Adocia (CE)
TG
MCHN
Invesco Markets II
BIT
F19198
Vontobel Financial Produ...
EU
5360T
5360T
COIN
GODEUR
Bitcoin God
EU
FRSG00014IH9
SG Issuer Sg Issuer Zc F...
LSE
SSOB
Etfs Ssob
LSE
34FB
Hitachi C. 21
AMEX
BZC
EU
SGFK
Societe Generale Domesti...
NASDAQ
CFIV
CF Acquisition Corporati...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten